EUCLID LABS, INC. — Form D/A
EUCLID LABS, INC. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2023-02-03. The offering totals $27.6M, of which $27.6M was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-02-03
- Form: D/A
- Accession: 0001918964-23-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $27.6M
- Amount sold: $27.6M
- Minimum investment: $1
- Investors: 42
- Date of first sale: 2022-03-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-438618
Issuer
- Name: EUCLID LABS, INC.
- CIK: 0001918964
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 332 PINE ST SUITE 800, SAN FRANCISCO, CA, 94104
- Phone: 415-422-9319
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Zhuoxun Yin | Director | San Francisco, CA |
| Zhuoxun Yin | Executive Officer | San Francisco, CA |
| Ailin Pallisso Poux | Executive Officer | San Francisco, CA |
| Joseph Doll | Director | San Francisco, CA |
| Tan Lu | Director | San Francisco, CA |
| Tan Lu | Executive Officer | San Francisco, CA |
| Kumars Akhavan | Director | San Francisco, CA |
| Daniel Burstein | Executive Officer | San Francisco, CA |
| Sida Zhang | Director | Grand Cayman, E9 |
| Sida Zhang | Executive Officer | Grand Cayman, E9 |
| Zhuojie Zhou | Director | Grand Cayman, E9 |
| Zhuojie Zhou | Executive Officer | Grand Cayman, E9 |
| ZHUOJIE ZHUO | Director | SAN FRANCISCO, CA |
| ZHUOJIE ZHUO | Executive Officer | SAN FRANCISCO, CA |
Other filings by this issuer (8)
More